ONCOLYTICS BIOTECH INC.: cashflow_financing

Value{"amount": 4183000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2025-01-01 – 2025-03-31
Statuscurrent
EntityONCOLYTICS BIOTECH INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001129928-26-000033 · Open the official SEC filing →
Retrieved: 2026-08-19T11:20:03.381402+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001129928/cashflow-financing/2025-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/69a14872-239b-4118-8fe5-3d0ab797be9c

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies